SSY Group (HKSE:02005) Change In Receivables : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is SSY Group Change In Receivables?

SSY Group's change in receivables for the quarter that ended in Dec. 2023 was HK$0 Mil. It means SSY Group's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

SSY Group's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-485 Mil. It means SSY Group's Accounts Receivable increased by HK$485 Mil from Dec. 2022 to Dec. 2023 .

SSY Group's Accounts Receivable for the quarter that ended in Dec. 2023 was HK$1,988 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SSY Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 115.91.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SSY Group's liquidation value for the six months ended in Dec. 2023 was HK$-1,048 Mil.

SSY Group Change In Receivables Historical Data

The historical data trend for SSY Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SSY Group Change In Receivables Chart

SSY Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-572.39

-204.98

-535.65

-797.62

-485.40

SSY Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

SSY Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

SSY Group (HKSE:02005) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SSY Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1987.818	/	3129.852	*	91
=	115.91

2. In Ben Graham's calculation of liquidation value, SSY Group's accounts receivable are only considered to be worth 75% of book value:

SSY Group's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1615.208	-	4697.644	+	0.75 * 1987.818	+	0.5 * 1086.282
=	-1,048

SSY Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of SSY Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

SSY Group (HKSE:02005) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SSY Group Ltd (HKSE:02005) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG

Website

http://www.ssygroup.com.hk

SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

SSY Group (HKSE:02005) Headlines

No Headlines